Entera Bio Ltd. Annual Deferred Income Tax Expense (Benefit) in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Entera Bio Ltd. annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2020 to 2024.
  • Entera Bio Ltd. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
  • Entera Bio Ltd. annual Deferred Income Tax Expense (Benefit) for 2024 was $14K, a 51.7% decline from 2023.
  • Entera Bio Ltd. annual Deferred Income Tax Expense (Benefit) for 2023 was $29K, a 83.3% decline from 2022.
  • Entera Bio Ltd. annual Deferred Income Tax Expense (Benefit) for 2022 was $174K.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $14K -$15K -51.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 $29K -$145K -83.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
2022 $174K +$391K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 -$217K -$217K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.